Markets and policymakers across Europe are juggling fiscal pressure, political risk, and long-term bets on…
Latest News
-
-
Big market moves are colliding with mixed economic signals as investors head into year-end. US…
-
HSBC’s senior research analyst Rajesh Kumar believes Novo Nordisk (NYSE: NVO) “might have an edge”…
-
US stocks extended a four-day winning streak as semiconductor giants and AI plays lifted the…
-
Starfighters Space (FJET) crashed over 50% today as early investors opted to take profit in…
-
Broadcom stock (NASDAQ: AVGO) climbed Tuesday as investors reassessed the chipmaker’s ability to convert a…
-
The recently launched ‘GenAI’ tool for U.S. service members and Department of War workers is…
-
As the year closes, Republicans are looking to the past for another dance with a…
-
Obamacare subsidies that have dominated the conversation on Capitol Hill are set to expire after…
-
Editor's Pick
Trump promises cheaper drugs under TrumpRx, but economists say the long-term costs may be hidden
As President Donald Trump rolls out his TrumpRx proposal to cut prescription drug prices, economists…